Insmed Inc. Stock
Price
Target price
€49.00
€49.00
4.700%
2.2
4.700%
€52.40
30.05.24 / Stuttgart Stock Exchange
WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insmed Inc. Stock
Insmed Inc. dominated the market today, gaining €2.20 (4.700%).
With 28 Buy predictions and 2 Sell predictions Insmed Inc. is one of the favorites of our community.
As a result the target price of 52 € shows a slightly positive potential of 6.12% compared to the current price of 49.0 € for Insmed Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insmed Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insmed Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 4.700% | 131.132% | 111.207% | 175.281% | 71.329% | 145.000% | 121.920% |
| Ardelyx Inc. | 3.070% | 1.608% | 5.441% | 102.500% | 9.308% | 7.085% | - |
| Evolus Inc | - | 0.000% | 7.477% | 37.725% | 27.072% | 32.948% | - |
| Salarius Pharmaceuticals Inc. | - | -3.015% | -6.311% | -66.724% | -30.450% | -98.501% | -99.994% |
Comments
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Stifel Nicolaus from $39.00 to $67.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at TD Cowen from $45.00 to $67.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at UBS Group AG from $46.00 to $58.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat
